Source: Annual Congress 2004 - Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Okutan, Z. Kartaloglu, A. Ilvan, E. Bozkanat, E. Demirer, E. Silit, S. Yildirim, Y. Narin (Istanbul, Turkey). Familial pulmonary alveolar microlithiasis(Report of two siblings). Eur Respir J 2004; 24: Suppl. 48, 4086

Member's Comments

No comment yet.

Related content which might interest you: Familial pulmonary fibrosis Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021 Familial idiopathic pulmonary fibrosis and "genetic anticipation" Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Association of pulmonary alveolar proteinosis and fibrosis: patient with GATA2 deficiency Source: Eur Respir J 2016; 48: 1510-1514 Year: 2016 Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis Source: Eur Respir J, 49 (5) 1700178; 10.1183/13993003.00178-2017 Year: 2017 Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis Source: Eur Respir J, 49 (5) 1700407; 10.1183/13993003.00407-2017 Year: 2017 Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations Source: Eur Respir J 2011; 37: 201-204 Year: 2011 Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis Source: International Congress 2019 – CCC Airway diseases Year: 2019 Pulmonary alveolar microlithiasis in two young siblings: case report Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Familial cases of idiopathic pulmonary fibrosis: Clinical observation Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 The analysis of alveolar macrophage form in secondary pulmonary alveolar proteinosis complicated with myelodysplastic syndrome. Source: International Congress 2017 – Rare diseases Year: 2017 Lung fibrosis in Pulmonary Alveolar Proteinosis (PAP): different stages of a syndrome or distinct diseases? Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Our cases with pulmonary alveolar proteinosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Diffuse lung disease and pulmonary hypertension related to TBX4 mutation in 5 children Source: International Congress 2019 – A mixture of rare lung diseases Year: 2019 Diffuse pulmonary development disorders- Molecular definable causes of pulmonary hypertension in the mature newborn Source: International Congress 2015 – Neonatal and paediatric intensive care Year: 2015 Morphometric characteristic of pulmonary artery in COPD and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 354s Year: 2006 Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Possible ocular involvement in pulmonary alveolar proteinosis Source: Eur Respir J 2006; 28: 456 Year: 2006 Idiopathic pulmonary haemosiderosis revisited Source: Eur Respir J 2004; 24: 162-169 Year: 2004